Meredith Meacham, PhD

TitlePostdoctoral Scholar
InstitutionUniversity of California San Francisco
Address401 Parnassus Ave.
San Francisco CA 94143
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    University of California San FranciscoPostdoctoral Fellowship2018Drug Abuse Treatment and Services Research, Digital Health
    UC San Diego/San Diego State UniversityPhD, Global Public Health2015Joint Doctoral Program in Public Health
    University of WashingtonMPH, Public Health Genetics2009School of Public Health
    University of ChicagoAB, Political Science2005The College
    Collapse Awards and Honors
    College on Problems of Drug Dependence2018Early Career Investigator Award
    University of California Los Angeles2015Center for Advancing Longitudinal Drug Abuse Research Travel Award
    National Institute on Drug Abuse2015NIDA Director's Travel Award
    University of California San Diego2013Center for Iberian and Latin American Studies Travel Grant to Brazil
    U.S. Department of State2006  - 2007Fulbright Fellowship to the European Union/Portugal

    Collapse ORNG Applications 
    Collapse Global Health

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Meacham MC, Paul MJ, Ramo DE. Understanding emerging forms of cannabis use through an online cannabis community: An analysis of relative post volume and subjective highness ratings. Drug Alcohol Depend. 2018 07 01; 188:364-369. PMID: 29883950.
      View in: PubMed
    2. Thrul J, Meacham MC, Ramo DE.A novel and remote biochemical verification method of smoking abstinence for digital health trials: Participant predictors of compliance. Tobacco Prevention & Cessation. 2018; 4.
    3. Horyniak D, Strathdee SA, West BS, Meacham M, Rangel G, Gaines TL. Predictors of injecting cessation among a cohort of people who inject drugs in Tijuana, Mexico. Drug Alcohol Depend. 2018 Feb 21; 185:298-304. PMID: 29482055.
      View in: PubMed
    4. Meacham MC, Ramo DE, Kral AH, Riley ED. Associations between medical cannabis and other drug use among unstably housed women. Int J Drug Policy. 2018 Feb; 52:45-51. PMID: 29227883.
      View in: PubMed
    5. Meacham MC, Roesch SC, Strathdee SA, Gaines TL. Perceived Treatment Need and Latent Transitions in Heroin and Methamphetamine Polydrug Use among People who Inject Drugs in Tijuana, Mexico. J Psychoactive Drugs. 2018 Jan-Mar; 50(1):62-71. PMID: 28960166.
      View in: PubMed
    6. Meacham MC, Roesch SC, Strathdee SA, Lindsay S, Gonzalez-Zuniga P, Gaines TL. Latent classes of polydrug and polyroute use and associations with human immunodeficiency virus risk behaviours and overdose among people who inject drugs in Tijuana, Baja California, Mexico. Drug Alcohol Rev. 2018 Jan; 37(1):128-136. PMID: 28337798.
      View in: PubMed
    7. Meacham MC, Strathdee SA, Rangel G, Armenta RF, Gaines TL, Garfein RS. Prevalence and Correlates of Heroin-Methamphetamine Co-Injection Among Persons Who Inject Drugs in San Diego, California, and Tijuana, Baja California, Mexico. J Stud Alcohol Drugs. 2016 Sep; 77(5):774-81. PMID: 27588536; PMCID: PMC5015469 [Available on 09/01/17].
    8. Werb D, Kamarulzaman A, Meacham MC, Rafful C, Fischer B, Strathdee SA, Wood E. The effectiveness of compulsory drug treatment: A systematic review. Int J Drug Policy. 2016 Feb; 28:1-9. PMID: 26790691; PMCID: PMC4752879 [Available on 02/01/17].
    9. Collins KM, Abramovitz D, Meacham MC, Gonzalez-Zuniga PE, Patrick K, Garfein RS.Cell phone access among persons who inject drugs in Tijuana, BC, Mexico. Journal of Mobile Technology in Medicine. 2015; 3(4):13-19.
    10. Meacham MC, Rudolph AE, Strathdee SA, Rusch ML, Brouwer KC, Patterson TL, Vera A, Rangel G, Roesch SC. Polydrug Use and HIV Risk Among People Who Inject Heroin in Tijuana, Mexico: A Latent Class Analysis. Subst Use Misuse. 2015; 50(10):1351-9. PMID: 26444185; PMCID: PMC4786000 [Available on 10/07/16].
    11. Kosterman R, Hill KG, Lee JO, Meacham MC, Abbott RD, Catalano RF, Hawkins JD. Young adult social development as a mediator of alcohol use disorder symptoms from age 21 to 30. Psychol Addict Behav. 2014 Jun; 28(2):348-58. PMID: 24955663; PMCID: PMC4215807.
    12. Meacham MC, Bailey JA, Hill KG, Epstein M, Hawkins JD. Alcohol and tobacco use disorder comorbidity in young adults and the influence of romantic partner environments. Drug Alcohol Depend. 2013 Sep 01; 132(1-2):149-57. PMID: 23428316; PMCID: PMC4035911.
    13. Bailey JA, Hill KG, Meacham MC, Young SE, Hawkins JD. Strategies for characterizing complex phenotypes and environments: general and specific family environmental predictors of young adult tobacco dependence, alcohol use disorder, and co-occurring problems. Drug Alcohol Depend. 2011 Nov 01; 118(2-3):444-51. PMID: 21636226; PMCID: PMC3179565.
    14. Meacham MC, Starks H, Burke W, Edwards K. Researcher perspectives on disclosure of incidental findings in genetic research. J Empir Res Hum Res Ethics. 2010 Sep; 5(3):31-41. PMID: 20831419; PMCID: PMC3413406.
    Meredith's Networks
    Derived automatically from this person's publications.
    People in Profiles who have published with this person.
    Related Authors
    People who share related concepts with this person.